Abstract:Background and objectives: A robust understanding of the natural history of apathy in Parkinson disease (PD) is foundational for developing effective clinical management tools. However, large longitudinal studies are lacking while the literature is inconsistent about even cross-sectional associations. We aimed to determine the longitudinal predictors of apathy development in a large cohort of people with PD and its cross-sectional associations and trajectories over time, using sophisticated Bayesian modeling techniques. Methods: People with PD followed up in the longitudinal New Zealand Parkinson's progression project were included. Apathy was defined using the neuropsychiatric inventory subscale ≥4, and analyses were also repeated using a less stringent cutoff of ≥1. Both MoCA and comprehensive neuropsychological testing were used as appropriate to the model. Depression was assessed using the hospital anxiety and depression scale. Cross-sectional Bayesian regressions were conducted, and a multistate predictive model was used to identify factors that predict the initial onset of apathy in nonapathetic PD, while also accounting for the competing risk of death. The relationship between apathy presence and mortality was also investigated. Results: Three hundred forty-six people with PD followed up for up to 14 years across a total of 1,392 sessions were included. Apathy occurrence did not vary significantly across the disease course (disease duration odds ratio [OR] = 0.55, [95% CI 0.28-1.12], affecting approximately 11% or 22% of people at any time depending on the NPI cutoff used. Its presence was associated with a significantly higher risk of death after controlling for all other factors (hazard ratio [HR] = 2.92 [1.50-5.66]). Lower cognition, higher depression levels, and greater motor severity predicted apathy development in those without motivational deficits (HR [cognition] = 0.66 [0.48-0.90], HR [depression] = 1.45 [1.04-2.02], HR [motor severity] = 1.37 [1.01-1.86]). Cognition and depression were also associated with apathy cross-sectionally, along with male sex and possibly lower dopaminergic therapy level, but apathy still occurred across the full spectrum of each variable (OR [cognition] = 0.58 [0.44-0.76], OR [depression] = 1.43 [1.04-1.97], OR [female sex] = 0.45 [0.22-0.92], and OR [levodopa equivalent dose] = 0.78 [0.59-1.04]. Discussion: Apathy occurs across the PD time course and is associated with higher mortality. Depressive symptoms and cognitive impairment in particular predict its future development in those with normal motivation.

Predictive Factors of Apathy in Stroke Survivors During the Recovery Period

Apathy After Stroke

Apathy and residual neurological impairment are associated with community reintegration after mild stroke

The Longitudinal Course of Post-Stroke Apathy over Five Years.

Apathy and Suicide-Related Ideation 3 Months after Stroke: a Cross-Sectional Study

Altered Resting-State Brain Activity and Functional Connectivity in Post-Stroke Apathy: An fMRI Study

Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease

Patient-Reported Variables Affecting Self-Perceived Overall Recovery Among People With Subacute Stroke

Prevalence and associated factors of apathy in Chinese ALS patients

Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study

Analysis of Influencing Factors of Apathy in Patients with Parkinson's Disease.

Apathy in Drug-Naïve Patients with Parkinson's Disease

Impact of early post-stroke affective and motivational disorders on functional outcome of ischemic stroke patients

The prevalence and risk factors of apathy among the Canadian long-term care residents with Alzheimer's disease and related dementias

The presence of anhedonia in individuals with subacute and chronic stroke: an exploratory cohort study

Predictors of functional independence and stress level of stroke survivors at discharge from inpatient rehabilitation

Prognostic Importance of Apathy in Syndromes Associated with Frontotemporal Lobar Degeneration.

Apathy in subarachnoid hemorrhage: study protocol for a 1-year follow-up study

Analysis of Related Factors of Depression in Patients with Aphasic Stroke

The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer's Disease

Investigating the Prevalence and Predictors of Apathy among the Canadian Long-Term Care Residents: A Secondary Data Analysis